Kroger Recalls Revlimid Due to Lack of Processing Controls
Kroger Specialty Pharmacy is recalling Revlimid 20 mg oral capsules because of a lack of processing controls. The recall affects specific lots distributed in MS, LA, AR, IL, and FL.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is FDA Class II due to a lack of processing controls, which presents a risk of harm where injury has not yet been reported. This aligns with the High severity criteria for risk-of-harm products without reported illness.
Plain-English summary
Kroger Specialty Pharmacy, Inc. is voluntarily recalling Revlimid 20 mg oral capsules, NDC 59572-0420-21, due to a lack of processing controls. This defect was identified in units dispensed between December 1, 2017, and February 12, 2018.
The recall covers all lots remaining within their expiry date that were distributed to Mississippi, Louisiana, Arkansas, Illinois, and Florida. The FDA has classified this recall as Class II.
Consumers who may have received these products should contact Kroger Specialty Pharmacy for more information or to return the medication.
The recalled product
- Product
- Revlimid 20 mg oral cap NDC 59572-0420-21 28 days supply
- Manufacturer
- Kroger Specialty Pharmacy, Inc.
- Category
- Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018
Distribution
Part of a larger recall action
This product is one of 67 recalled by Kroger Specialty Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same manufacturer · Kroger Specialty Pharmacy, Inc.
See all →- HighKroger Recalls Botox Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Capecitabine Tablets Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cimzia 200 mg/mL PFS Kits
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Lupron Depot Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cyclophosphamide Capsules Due to Processing Controls
FDA (Drugs) · 2018-05-16
Same hazard · processing control failure
See all →- ModerateB-Complex Injection Recalled Due to Lack of Processing Controls
FDA (Drugs) · 2021-12-22
- SevereRandall Ultimate 4-Bean Mix Recalled for Lack of Temperature Indicators
FDA (Food) · 2021-08-04
- HighRandall Garbanzo Beans Recall: Defective Temperature Monitoring Devices
FDA (Food) · 2021-08-04
- HighKroger Recalls Pulmozyme Inhalation Solution Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Sprycel Tablets Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16